Furthermore, serum apelin levels were correlated with shorter survival, higher incidence of cancer recurrence and resistance to anticancer drugs in some human solid tumors, such as gastric cancer, lung adenocarcinoma, and breast cancer [222]. This evidence concerns the gene APLN and breast carcinoma.